Iridium complex, method for manufacturing same, and organic light-emitting devices using same

Abstract

An iridium complex is disclosed. The iridium complex with new type primary ligand, and an auxiliary ligand of 4(3,5-pyrimidine) phosphonimidesas. The iridium complex of this series has primary ligand in molecule which is the any one derivative of the following ones: 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazinederivative;
the new type of iridium complex covered by the present invention has not only such advantages as high luminous efficiency, high electron mobility, stable chemical property, easy for distillation and purification but also good performance of devices.

Claims

1. An iridium complex comprising two primary ligands, and an auxiliary ligand of 4(3,5-pyrimidine) phosphonimidesas; wherein the primary ligand is selected from any one derivative of the following ones: 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazine; in the primary ligand, pyridine derivatives ligating with iridium by C atom are ##STR00016## the pyridine derivatives have different positions of linking with the pyridine, pyrimidine, pyrazinyl and triazine derivatives in different primary ligands, and the arbitrary positions of the pyridine, pyrimidine, pyrazinyl and triazine derivatives are substituted by halogen or alkyl, the number of substituent groups on pyridine is 0-4, that on pyrimidine and pyrazinyl is 0-3, that on triazine is 0-2.

2. The iridium complex as described in claim 1, wherein the halogen is F, the alkyl is any one of trifluoromethyl and methyl.

3. The iridium complex as described in claim 1, wherein the 4,6-bi trifluoromethyl in the primary ligands has different positions of linking with the pyridine, pyrimidine, pyrazinyl and triazine derivatives in different primary ligands, the positions are taken from 3-position and 4-position; the pyridine, pyrimidine, pyrazinyl and triazine derivatives are selected from any one of substituents of ##STR00017##

4. The iridium complex as described in claim 3, wherein the iridium complex has one of the following structures: ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024## ##STR00025## ##STR00026## ##STR00027## ##STR00028## ##STR00029## ##STR00030##

5. A manufacturing method of iridium complex comprising the steps of: mixing iridium dimer bridging ligand which contain two primary ligands, and an auxiliary ligand of 4(3,5-pyrimidine) phosphonimidesas and sodium carbonate; the primary ligands selected from any one derivative of the following ones: 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, and 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazine; then adding the mixed solution into 2-ethoxyethanol solution; conducting heating reaction under 120-140° C. for a reaction time of 12-48 h; cooling to room temperature; eliminating the solvent through vacuum distillation; then extracting and concentrating with dichloromethane; getting the crude product of the ligand through column chromatography isolation; and getting pure iridium complex through distillation.

6. The manufacturing method of iridium complex as described in claim 5, wherein the mole ratio of the iridium dimer bridging ligand: auxiliary ligand of 4(3,5-pyrimidine) phosphonimidesas: sodium carbonate is 1:2:5.

7. An organic light-emitting diode device applying the iridium complex as described in claim 1 comprising a substrate, an anode, a hole transport layer, an organic light-emitting layer, an electron transport layer and a cathode; wherein the substrate is glass, the anode is indium tin oxide, the hole layer is made of TAPC material, the electron transport layer is made of TmPyPB material, the organic light-emitting layer comprises body material and luminous material, the body material is 1,3-bis(9H-carbazol-9-yl)benzene/mCP, the luminous material comprises the iridium complex.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0008] FIG. 1 is an electroluminescent spectra of an iridium complex GIr7-001 used in an organic light-emitting device;

[0009] FIG. 2 is an photoelectric property of the iridium complex GIr7-001 used in the organic light-emitting device; and

[0010] FIG. 3 is an photoelectric property that the iridium complex GIr7-001 used in the organic light-emitting device.

DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENT

[0011] The present disclosure will hereinafter be described in detail with reference to an exemplary embodiment. To make the technical problems to be solved, technical solutions and beneficial effects of the present disclosure more apparent, the present disclosure is described in further detail together with the figure and the embodiment. It should be understood the specific embodiment described hereby is only to explain the disclosure, not intended to limit the disclosure.

[0012] All the iridium complexes of the invention have used iridium chloride hydrate, 4,6-2 -(trifluoromethyl)pyridine-3 -boric acid, 4,6-2-(trifluoromethyl)pyridine-4-boric acid, 2-bromopyridine derivatives, 2-bromopyrimidine derivatives, 2-bromopyrazine derivatives, 2-bromotriazine derivatives etc, in the synthesis process with the similar method of synthesis. Mix iridium dimer bridging ligand containing two primary ligand, and an auxiliary ligand of 4(3,5-pyrimidine) phosphonimidesas and sodium carbonate, the primary ligand is any one derivative of the following ones: [0013] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine, [0014] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, [0015] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, [0016] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, [0017] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, [0018] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, [0019] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine, [0020] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazine.

[0021] Then add the mixed solution into 2-ethoxyethanol solution, conduct heating reaction under 120-140° C. for a reaction time of 12-48 h, cool to room temperature, eliminate the solvent through depressurization and distillation, then extract and concentrate with dichloromethane, get the crude product of the ligand through column chromatography isolation, and get pure iridium complex through sublimation.

[0022] Wherein, the iridium dimer bridging ligand contains any one derivative of the following ones: [0023] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine, [0024] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, [0025] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, [0026] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, [0027] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, [0028] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, [0029] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine, [0030] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazine.

[0031] The mole ratio of the iridium dimer bridging ligand: the tetraphenylphosphorane: sodium carbonate is 1:2:5.

[0032] Iridium complex has one of the following structure:

##STR00001## ##STR00002## ##STR00003## ##STR00004## ##STR00005## ##STR00006## ##STR00007## ##STR00008## ##STR00009## ##STR00010## ##STR00011## ##STR00012## ##STR00013##

[0033] The invention is further described below with reference to one of the embodiments of complex GIr7-001, to help improve understanding of the invention, but not limit to the present invention.

[0034] Manufacturing method of complex GIr7-001

##STR00014##

[0035] Dissolve 2-bromopyridine(26.39 mmol), 4,6-4,6-2 -(trifluoromethyl)pyridine-3 -boric acid (31.66 mmol), tetrakis(triphenylphosphine) palladium (0.79 mmol) and sodium carbonate (60.00 mmol) in 10 mL of tetrahydrofuran, react under 65° C. for 24 hours and cool, add water and dichloromethane, then get the primary ligand through organic layer concentration column chromatography (yield of 52.24%). Dissolve the primary ligand (13.08 mmol) and iridium chloride hydrate into 15 mL of 2-ethoxyethanol, the mixture reacts under 130° C. for 12 h, then add 4(3,5-pyrimidine) phosphonimidesas (12.46 mmol) and sodium carbonate (60.00 mmol), then continue to react under 130° C. for 24 h. Systematic cooling, add water and dichloromethane, get yellow solid GIr7-001 through organic layer concentration column chromatography (yield of 44%).

[0036] NMR and mass spectrometry characterization:.sup.1H NMR (500 MHz, CDCl3) δ 9.09 (d, J=5.6 Hz, 2H), 8.29 (d, J=8.4 Hz, 2H), 7.78 (dd, J=12.4, 7.7 Hz, 4H), 7.66 (t, J=8.0 Hz, 2H), 7.37 (ddd, J=19.9, 13.9, 7.5 Hz, 6H), 7.16 (t, J=7.4 Hz, 2H), 7.04 (t, J=6.7 Hz, 4H), 6.83 (t, J=6.5 Hz, 2H). ESI-MS: m/z 1199.09 [M]+, found: 1198.83 [M]+.

[0037] The invention takes any one of [0038] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyridine [0039] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyridine, [0040] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrimidine, [0041] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrimidine, [0042] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)pyrazinyl, [0043] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)pyrazinyl, [0044] and 2-(4,6-pyridine2-(trifluoromethyl)pyridine-3-)triazinetriazine, [0045] 2-(4,6-pyridine2-(trifluoromethyl)pyridine-4-)triazinetriazined derivative as primary ligands, with 4(3,5-pyrimidine) phosphonimidesas as auxiliary ligand, to design and synthesize a series of green emitting iridium complexes. By design of ligand or complex structure, and by modification of simple chemical substituent on the ligand, it achieves the goal of regulating luminescence and electron mobility of the complex.

[0046] All the azacycles are groups with relatively high electron transmission performance, facilitating to balance the import and transmission of carriers.

[0047] The iridium complexes has relatively high luminous efficiency and high electron mobility, and can be prepared by simple method with high yield after optimization and verification.

[0048] Preparation of Organic Light-Emitting Diode Devices

[0049] Next the preparation of organic light-emitting diode devices of the invention is described, as exemplified with GIr7-001 as organic light-emitting diode devices. The OLED devices has a structure including: Substrate, anode, hole transmission layer, organic light-emitting layer, electron transmission layer and cathode.

[0050] In the device making of the invention, the substrate is glass, the anode material is indium tin oxide (ITO); the hole transmission layer is made of 4,4′-Cyclohexylidenebis[N,N-bis(4-methylphenyl)aniline] (TAPC), the electron transmission layer is made of 3,3′-(5′-(3-(pyridin-3-ylphenyl)phenyl)-[1,1′:3′,1″-triphenyl]-3,3″-diyl)bipyridine (TmPyPB) material, with a thickness of 60 nm and a vapor deposition rate of 0.05 nm/s; the cathode is made of LiF/Al, LiF with a thickness of 1 nm and a vapor deposition rate of 0.01 nm/s, Al with a thickness of 100 nm and a vapor deposition rate of 0.2 nm/s. The organic light-emitting layer is in a doped structure, the body is made of 1,3-bis(9H-carbazol-9-yl)benzene/mCP, the selected luminous material is GIr7-001. The light-emitting layer has a thickness of 40 nm, a vapor deposition rate of 0.05 nm/s, a GIr7-001 mass fraction of 8%.

[0051] The materials used in the invention have the following structures:

##STR00015##

[0052] The invention selects a green emitting complex for preparing organic light-emitting diode devices. Please refer to FIG. 1, FIG. 2 and FIG. 3, FIG. 1 is the electroluminescence spectrum of the iridium complex used for organic light-emitting diode devices provided by the invention, FIGS. 2 and 3 are the photoelectric properties of the iridium complex used for organic light-emitting diode devices provided by the invention. As shown in FIGS. 2 and 3, the maximum power efficiency and current efficiency of the organic light-emitting diode devices are 45.11 lm/W and 99.15 cd/A respectively, with a maximum luminance of 48214 cd/m2. Through studies of photophysical properties, the phosphorescent iridium complexes containing azacycle have actual application value in the fields of display and lighting.

[0053] The phosphorescent material provided by the invention can act as luminescence center and applied in emitting layer of phosphorescent OLED, by design of ligand or complex structure, and by modification of chemical substituent of the ligand, the invention achieves the goal of regulating emitting color and efficiency.

[0054] It is to be understood, however, that even though numerous characteristics and advantages of the present exemplary embodiment have been set forth in the foregoing description, together with details of the structures and functions of the embodiment, the disclosure is illustrative only, and changes may be made in detail, especially in matters of shape, size, and arrangement of parts within the principles of the invention to the full extent indicated by the broad general meaning of the terms where the appended claims are expressed.